GlaxoSmithKline
Last updated on 2013-11-22T06:52+0300.
About this
image
License:
UNKNOWN
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|---|---|---|
| british rival | 50.00% | EN | 02/02/2007 |
| candidate | 50.00% | EN | 15/11/2005 |
| Names | Lang | Count |
|---|---|---|
| GlaxoSmithKline | EN | 22.94% |
| GlaxoSmithKline | FR | 8.56% |
| GlaxoSmithKline | PT | 5.87% |
| GlaxoSmithKline | ES | 5.26% |
| GlaxoSmithKline | DE | 5.20% |
| GlaxoSmithKline | AF | 5.20% |
| GlaxoSmithKline | PL | 5.20% |
| GlaxoSmithKline | TR | 5.20% |
| GlaxoSmithKline | NN | 5.20% |
| GlaxoSmithKline | RU | 5.20% |
| GlaxoSmithKline | NO | 5.20% |
| GlaxoSmithKline | UK | 5.20% |
| GlaxoSmithKline | HR | 5.20% |
| GlaxoSmithKline | AR | 5.20% |
| Glaxo Smith Kline | EN | 0.98% |
| GLAXOSMITHKLINE | EN | 0.90% |
| Glaxo Smith Kline | FR | 0.90% |
| Glaxo Smith Kline | SV | 0.84% |
| Glaxo-Smith-Kline | DE | 0.53% |
| GlaxoSmithKline | SA | 0.39% |
| Glaxo Smithkline | ES | 0.29% |
| Glaxo Smithkline | EN | 0.29% |
| Glaxo Smith Klein | EN | 0.12% |
| Glaxo SmithKline | EN | 0.10% |
| GLAXOSMITHKLINE | FR | 0.06% |
| Glaxo Smithkline | FR | 0.02% |
| GLAXOSMITHKLINE | SA | 0.02% |
| Pharmakonzern Glaxo Smithkline | DE | 0.00% |
| 葛蘭素史克 | ZH | 0.00% |
| Pharmariesen Glaxo Smith Kline | DE | 0.00% |
| Type | Entity Name | Count |
|---|---|---|
 | Pfizer Inc | 4.22% |
| Inc | 3.70% |
 | Elliott Management | 2.75% |
| Michael Hewson | 2.01% |
| Bloomberg LP | 1.80% |
| Swedish | 1.69% |
| London Stock Exchange | 1.69% |
| John Dawson | 1.69% |
| Global Inc | 1.48% |
| British | 1.48% |
| Federal Reserve | 1.37% |
| Donald Trump | 1.27% |
| European Union | 1.27% |
| Dow Jones | 1.16% |
| Federal Reserve System | 0.95% |
| Bloomberg News | 0.95% |
| Reuters Group | 0.95% |
| JPMorgan Chase & Co | 0.84% |
| Dan Gilbert | 0.84% |
| Viraj Patel | 0.84% |
| Michael Wolf | 0.84% |
| The Australian | 0.84% |
| World Health Organization | 0.84% |
| 0.84% | |
| The UK | 0.84% |
| Goldman Sachs | 0.74% |
| recent changes | 0.74% |
| Commission | 0.74% |
| Novartis | 0.74% |
| Jeff Bezos | 0.74% |
| Type | Entity Name | Score |
|---|---|---|
| Elliott Management | 0.0197 |
| Michael Hewson | 0.0197 |
| London Stock Exchange | 0.0164 |
| John Dawson | 0.016 |
| Global Inc | 0.0119 |
| Swedish | 0.0118 |
| Bill Sellers | 0.0116 |
| Bloomberg LP | 0.009 |
| Michael Wolf | 0.0081 |
| Dan Gilbert | 0.008 |
| Viraj Patel | 0.0078 |
| Guadalupe Ramirez | 0.0078 |
| Pfizer Inc | 0.0074 |
| Dow Jones | 0.0072 |
| recent changes | 0.007 |
| Novartis | 0.0069 |
| Bloomberg News | 0.0066 |
| Federal Reserve System | 0.0064 |
| The Australian | 0.0062 |
| Eli Lilly | 0.0062 |
| Federal Reserve | 0.0058 |
| Paul Singer | 0.0058 |
| Jeff Bezos | 0.0057 |
| Inc | 0.0056 |
| Goldman Sachs | 0.0054 |
| General Electric | 0.0052 |
| Jet Blue | 0.0051 |
| JPMorgan Chase & Co | 0.005 |
| GlaxoSmithKline Plc | 0.005 |
| Long Term | 0.005 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Tuesday, April 20, 2021
1:36:00 AM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 